| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/15/2014 | EP2683377A1 Combination therapies for hematologic malignancies |
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | EP1037926B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/15/2014 | CN103517922A Antibodies directed against ICOS and uses thereof |
| 01/15/2014 | CN103517904A Alpha helix mimetics and methods relating thereto |
| 01/15/2014 | CN103517903A Pyrrolopyridineamino derivatives as MPS1 inhibitors |
| 01/15/2014 | CN103517895A Metal-salen complex compound and production method for same |
| 01/15/2014 | CN103517719A Antibody-drug conjugates |
| 01/15/2014 | CN103517717A Methods to enhance cell-mediated immunity |
| 01/15/2014 | CN103509868A Application of nucleotide sequence |
| 01/15/2014 | CN103509671A Fermentation-type cactus fruit juice tea wine production method |
| 01/15/2014 | CN103509119A Recombinant fusion protein of short peptide hormone and recombinant pseudomonas exotoxin A and application thereof |
| 01/15/2014 | CN103509117A Bispecific antibody capable of resisting human epidermal growth factor receptor 2 (HER2) and human insulin-like growth factor-IR (IGF-IR), and preparation method and applications thereof |
| 01/15/2014 | CN103509116A 抗体纯化 Antibody Purification |
| 01/15/2014 | CN103509114A Monoclonal antibodies against claudin-18 for treatment of cancer |
| 01/15/2014 | CN103509113A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 01/15/2014 | CN103509112A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 01/15/2014 | CN103509111A Human anti-KIR antibodies |
| 01/15/2014 | CN103509110A Monoclonal antibodies against claudin-18 for treatment of cancer |
| 01/15/2014 | CN103509091A Grifola frondosa mycelium anti-tumor glycoprotein and preparation method |
| 01/15/2014 | CN103509078A Glycyrrhizic acid derivative and preparation method thereof |
| 01/15/2014 | CN103509077A Triterpene saponin compound, its preparation method and applications |
| 01/15/2014 | CN103509070A Extraction method and application of total glucosides of paeony |
| 01/15/2014 | CN103509059A Cyclometalated ruthenium complex, and preparation method and application thereof |
| 01/15/2014 | CN103509046A Bis(tri(2-methyl-2-phenyl propyl)tin) dicarboxylic ester and preparation method and application thereof |
| 01/15/2014 | CN103509030A Camptothecin compounds, and preparation and applications thereof |
| 01/15/2014 | CN103509029A Phenanthroquinolizidine alkaloid derivatives and salts thereof, and preparation, anti-plant virus activity and anti-cancer activity of phenanthroquinolizidine alkaloid derivatives and salts thereof |
| 01/15/2014 | CN103509024A Pyrimidobenzoazepine compound and application thereof as anti-tumor medicine |
| 01/15/2014 | CN103509017A Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors |
| 01/15/2014 | CN103509015A Salts of 14-hydroxyantofine derivative |
| 01/15/2014 | CN103509014A Salts of antofine derivatives |
| 01/15/2014 | CN103509013A Salts of delta 11,12-antofine derivatives |
| 01/15/2014 | CN103509011A 1-(4-hydroxy-3-formyl amino acid-phenyl)-beta-carboline, preparation method thereof, anti-inflammatory and antitumor activities thereof, and application thereof |
| 01/15/2014 | CN103509009A 2-substituted-5-phenyl furan compound, and preparation method, pharmaceutical composition and application thereof |
| 01/15/2014 | CN103509008A Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/15/2014 | CN103509007A Flumatinib mesylate crystal form and preparation method and use thereof |
| 01/15/2014 | CN103509006A Flumatinib mesylate crystal form, and preparation method and use thereof |
| 01/15/2014 | CN103509005A Quinazoline compound as well as preparation method and application thereof |
| 01/15/2014 | CN103508981A New piperazine derivative and medical applications |
| 01/15/2014 | CN103508961A Antitumor drug |
| 01/15/2014 | CN103508944A Crystal form A of N-((4-chloro-3-trifluoromethyl)phenyl)-N'-((2-fluoro-4-(2-formamyl)-4-pyridyloxy)phenyl)urea and preparation method thereof |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN103505743A Cell micro-particles containing functional microRNA/siRNA and application thereof |
| 01/15/2014 | CN103505741A Tegafur-layered double-metal hydroxide nanometer hybrid modified with polyethylene glycol derivative on surface and preparation of nanometer hybrid |
| 01/15/2014 | CN103505737A Method for preparing docetaxel/beta-cyclodextrin clathrates |
| 01/15/2014 | CN103505732A Tumor treatment synergism combination drug |
| 01/15/2014 | CN103505730A Copper selenide/mesoporous silica core-shell nanoparticles and preparation method and application thereof |
| 01/15/2014 | CN103505727A Application of novel function of CD146 targeted as co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2) in anti-tumor angiogenesis treatment |
| 01/15/2014 | CN103505722A Application of interferon in treating/preventing tumors with resistance to conventional antineoplastic therapies, and related product and method |
| 01/15/2014 | CN103505698A Traditional Chinese medicine composition for treating malignant lymphoma |
| 01/15/2014 | CN103505679A Drug for treating blood diseases, preparation method, and applications thereof |
| 01/15/2014 | CN103505670A Traditional Chinese medicine composition for treating primary bronchus lung cancer |
| 01/15/2014 | CN103505631A Traditional Chinese medicine composition for treating chronic leukemia |
| 01/15/2014 | CN103505598A Traditional Chinese medicine composition for treating infertility |
| 01/15/2014 | CN103505517A Preparation method and application of gastralgia tablets |
| 01/15/2014 | CN103505501A New application of Yupingfeng particles |
| 01/15/2014 | CN103505486A Lucid ganoderma-American ginseng granule and preparation method thereof |
| 01/15/2014 | CN103505480A Punica granatum peel antitumor polyphenol effective part, its preparation method and application |
| 01/15/2014 | CN103505458A Application of autophagy inhibitor in preparation of tumor multidrug resistance reversal agent |
| 01/15/2014 | CN103505454A Alpha-tubulin inhibitor and application thereof |
| 01/15/2014 | CN103505450A Application of lobaplatin in preparation of drugs used for treating prostate cancer |
| 01/15/2014 | CN103505448A Method of using rhein for treating fibrotic conditions and tumors |
| 01/15/2014 | CN103505445A New application of dimethyldiguanide |
| 01/15/2014 | CN103505444A Application of germacrone in preparation of liver cancer treatment medicines |
| 01/15/2014 | CN103505442A Target nano lipid core micelle used for carrying docetaxel, and preparation method and applications thereof |
| 01/15/2014 | CN103505424A Preparation method for bortezomib for injection |
| 01/15/2014 | CN103505418A Medical carrier and medical composition and preparation methods of medical carrier and medical composition |
| 01/15/2014 | CN103031334B Dual-target siRNA eukaryotic expression plasmid capable of inhibiting STAT3 and AFP gene expression, and application of expression plasmid |
| 01/15/2014 | CN102732515B Nucleotide sequence and application thereof |
| 01/15/2014 | CN102716465B Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite |
| 01/15/2014 | CN102701992B Anti-tumour compound, pharmaceutically accepted salts as well as preparation method and application thereof |
| 01/15/2014 | CN102697720B Irinotecan hydrochloride lipid nanoparticles injection |
| 01/15/2014 | CN102675134B Nitrogen-containing substituent curcumin analogue and medical application thereof |
| 01/15/2014 | CN102652762B Application of effective parts of common andrographis herbs |
| 01/15/2014 | CN102626412B Pharmaceutical composition for curing malignant tumor |
| 01/15/2014 | CN102584916B Lignan triglucoside compound and preparation method and application thereof |
| 01/15/2014 | CN102584914B Glucoside ester compound and preparation method and application thereof |
| 01/15/2014 | CN102558296B Mytilus edulis enzymolysis polypeptide and preparation method and application thereof |
| 01/15/2014 | CN102526154B Method for preparing antitumor medicine burdock root extractive |
| 01/15/2014 | CN102423484B Stable cetrorelix medicinal composition and preparation method thereof |
| 01/15/2014 | CN102391204B Chiral 2,4-disubstituted-thaizolidinone compounds and preparation method and application thereof in preparation of anticancer medicaments |
| 01/15/2014 | CN102382064B Quinnazolidone derivative, preparation method for same and application thereof |
| 01/15/2014 | CN102357189B Traditional Chinese medicine for radiotherapy regulation and nourishment |
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102329319B Novel crystal form for temozolomide, method for preparing temozolomide and medicinal composition of temozolomide |
| 01/15/2014 | CN102250203B Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
| 01/15/2014 | CN102197030B Rotaxane compound and antitumor agent |
| 01/15/2014 | CN102188382B DSPE-PEG-FA-modified nanometer paclitaxel liposome and preparation method thereof |
| 01/15/2014 | CN102146418B Recombinant II type herpes simplex virus vector, preparation method of recombinant II type herpes simplex virus vector, recombinant virus, medicinal composition and application |
| 01/15/2014 | CN102099468B Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 01/15/2014 | CN102070614B Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
| 01/15/2014 | CN102060903B Ginsenoside Rh2 extractive and preparation method thereof |
| 01/15/2014 | CN101827611B Combination therapy of a type II anti-CD20 antibody with an anti-Bcl-2 active agent |
| 01/15/2014 | CN101824083B C-terminal deletion type p43 protein and application thereof in medicaments for treating tumor |
| 01/15/2014 | CN101809037B Human antibodies to human cd20 and method of using thereof |
| 01/15/2014 | CN101778639B Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 01/15/2014 | CN101723936B Kinase suppressor and pharmaceutical application thereof |
| 01/15/2014 | CN101547903B 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate |
| 01/15/2014 | CN101506188B Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| 01/14/2014 | US8629317 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications thereof |